FormDSignal
0

Bio Essence Corp (BIOE): director Thea Zhang elected to the board

BIOE · OTC · Pharmaceutical Preparations · Non-accelerated filer<br>Smaller reporting company · CA · Form 8-K filed 2026-10-23

Thea Zhang and Geoff Fellows elected as Directors of Bio Essence Corp. on October 19, 2026.

Board election

Events in this filing

2 events: Board election (Director), Board election (Director).

Names, stated reasons, successor status, compensation terms and the evidence quotes are shown to subscribers. See plans

Item 5.02 as filed

Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers
On October 19, 2026, a majority of shareholders
of Bio Essence Corp., a California corporation (“Company”) elected by way of written consent Thea Zhang and Geoff Fellows
as a Directors of the Company.
Ms. Zhang is a strategic business and operations
leader with more than fifteen years of experience overseeing business operations, manufacturing strategy, and product commercialization.
She previously worked for Spyglass Pharma, Inc., as a Senior Manager, and Oasis Medical, Inc., in the same role. Ms. Zhang received a
Master’s Degree in Business Administration from the University of Toledo, and a Bachelor’s Degree in Engineering – Pharmaceutical
Science from Nanjing University of Technology in Nanjing, China.
Mr. Fellows similarly has experience as a business leader, with years of experience in the industry. He is the chief executive officer
of Embarcadero Accessible Multi-Family Office, where he has historically overseen the firm’s tax and legal departments. Mr. Fellows
brings more than three decades of experience in finance, operations, compliance, and governance from across the financial services industry
to the Board.
Ms. Zhang and Mr. Fellows have no arrangement
or understanding regarding their appointment, nor are they a party to any material plan, contract, or arrangement, and no transactions
disclosable pursuant to Item 404(a) of Regulation S-K.
Source filing on EDGAR →